Attached files

file filename
8-K - FORM 8-K - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_8k.htm
EX-3.2 - BYLAWS, AS CURRENTLY IN EFFECT - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex32.htm
EX-10.2 - AGREEMENT - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex102.htm
EX-23.1 - CONSENT OF CHERRY, BEKAERT & HOLLAND, L.L.P. - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex231.htm
EX-21.1 - AGREEMENT AND PLAN OF MERGER BY AND AMONG GOLF TRUST OF AMERICA, INC., - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex211.htm
EX-10.1 - 2009 STOCK INCENTIVE PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex101.htm
EX-99.1 - COWEN AND COMPANY HEALTHCARE CONFERENCE PRESENTATION DATED MARCH 10, 2010 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex991.htm
EX-10.3 - EMPLOYMENT AND NON-COMPETE AGREEMENT, DATED DECEMBER 31, 2008, BY AND BETWEEN PERNIX THERAPEUTICS, INC. AND MICHAEL VENTERS - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex103.htm
EX-10.4 - EMPLOYMENT NON-COMPETE AGREEMENT, DATED JUNE 1, 2008, BY AND BETWEEN PERNIX THERAPEUTICS, INC. AND COOPER COLLINS - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex104.htm
EX-3.1 - ARTICLES OF INCORPORATION, AS CURRENTLY IN EFFECT - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex31.htm
EXHIBIT 16.1
 
March 12, 2010
 
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
 
We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on October 14, 2009, to be filed by our former client, Pernix Therapeutics Holdings, Inc. (formerly Zyber Pharmaceuticals, Inc.).  We agree with the statements made in response to that Item insofar as they relate to our Firm.
 

Very truly yours,
 

BDO Seidman, LLP
 
cc: Jan Loeb, Audit Committee Chair; Tracy Clifford, Chief Financial Officer